Contraceptive consultation: a checklist for your first visit

You may leave with a prescription, a method-start plan, a referral for insertion, or a reason to pause and gather more information.

The questions a clinician asks are also rarely the questions people rehearse at home. They are less about finding a universally “best” method and more about identifying what is medically safe, practically realistic, and acceptable to you over time. A method can be highly effective on paper and still be a poor fit if it clashes with your bleeding pattern, daily routine, budget, relationship circumstances, or plans for pregnancy.

One Canadian survey found that roughly a quarter of reproductive-age women were dissatisfied with their current contraceptive method. That finding establishes how common dissatisfaction can be; it does not establish that those respondents had never tried another method or that dissatisfaction was caused by one particular kind of counseling. The useful lesson is narrower and more practical: a consultation has a better chance of producing a workable choice when the trade-offs are discussed clearly at the start.

A useful first contraceptive visit is the one where you arrive knowing more about your own body than you expect a stranger to ask about.

Compiling your medical and menstrual history

The history is not paperwork before the “real” appointment. It is the main material from which a safe recommendation is built. Clinicians use risk-based guidance, including the U.S. Medical Eligibility Criteria for Contraceptive Use, to identify conditions that make some methods unsuitable or require additional caution. Much of that information cannot be inferred from an examination or a blood pressure reading alone.

Start with your menstrual timeline

Bring the first day of your most recent period if you know it. If your cycles are irregular, describe the pattern rather than trying to force it into an average:

• the shortest and longest cycles you have noticed;
• missed periods or long gaps;
• bleeding between periods or after sex;
• how heavy the bleeding is and how many days it usually lasts;
• cramps, pelvic pain, or symptoms that interfere with work, school, sleep, or exercise;
• whether your bleeding changed after pregnancy, an abortion, emergency contraception, or a previous contraceptive method.

A cycle-tracking app can help, but it is not essential. A note in your phone or a paper calendar is enough. The point is to give the clinician a baseline and to make clear which symptoms predated a new method.

This information matters differently depending on the method under discussion. For fertility-awareness-based approaches, cycle patterns are central to the method itself. For an IUD or hormonal contraception, the baseline helps distinguish an expected adjustment from a new problem that deserves assessment. If pregnancy is possible, the timing of the last period and any recent unprotected sex also help determine whether a method can be started immediately or whether further evaluation is needed.

Bring every medication, not only prescriptions

Write down prescription medicines, over-the-counter drugs, supplements, and herbal products. Include the dose if you know it and how often you take it. A photograph of the medication labels is often easier than reconstructing the list in the waiting room.

Some enzyme-inducing medicines can reduce the effectiveness of certain hormonal contraceptives. This includes particular anti-seizure medicines and rifampin or rifabutin, which are used in some infection-treatment regimens. St. John’s wort can also interact with hormonal contraception. Some medicines used in HIV treatment and other specialist regimens require a method-specific review rather than a generic warning.

Do not stop a medication because you are worried about an interaction. Bring the information to the appointment and ask whether the contraceptive method, the medication, or both need to be adjusted. A pharmacist can also be a useful source of interaction information, particularly when the appointment is brief.

Flag conditions that change the options

Some health conditions affect the safety of particular methods, especially those containing estrogen. Mention them even if they seem unrelated to contraception:

• migraine, especially migraine with aura;
• current or previous blood clots, stroke, or significant clotting disorders;
• high blood pressure or treatment for hypertension;
• smoking or nicotine use, including how much and how often;
• liver disease or a history of liver tumors;
• current or previous breast cancer;
• diabetes and any vascular complications;
• recent childbirth, miscarriage, or abortion;
• surgery or periods of prolonged immobility;
• unexplained vaginal bleeding;
• medicines for epilepsy, tuberculosis, HIV, or other chronic conditions.

Combined hormonal contraception — the pill, patch, and ring — is not automatically appropriate for everyone with one of these risk factors. Nor does one answer settle the entire conversation. The details matter: the type and severity of migraine, the level of blood pressure, the amount smoked, the presence of additional cardiovascular risks, and whether a condition is current or historical can all change the recommendation.

Smoking after age 35 is a good example of why shorthand rules are unhelpful. Age and smoking together can increase cardiovascular risk, but eligibility is not determined by age alone. The amount smoked and other risk factors matter, and the risk categories distinguish among different levels of exposure. The practical move is to give an accurate account rather than assume that a single label automatically rules out every combined hormonal option.

Reconstruct previous contraceptive experiences

If you have used contraception before, make a short record of:

• the method and, if relevant, the brand or formulation;
• how long you used it;
• when symptoms began;
• why you stopped;
• whether you missed doses or had trouble obtaining refills;
• whether you would consider trying it again;
• what changed in your life since then.

The reason for stopping is often more informative than the method’s name. “The pill did not work for me” could mean persistent bleeding, worsening headaches, mood changes, difficulty taking it every day, cost, a change in insurance, fear after a missed pill, or a pregnancy that occurred while using it. Those situations lead to different next steps.

If a previous method caused a problem, describe the problem without having to prove that the method caused it. A clinician can help separate a likely side effect from a symptom that needs its own evaluation. The aim is not to defend or discredit a previous choice. It is to avoid repeating a mismatch because the relevant detail was compressed into a single sentence.

The eligibility checklist runs on your history. If the history is incomplete, the recommendation is guesswork.

Navigating clinical requirements: exams and screenings

What has to happen before contraception is prescribed or provided depends on the method and on the clinical situation. Many people expect a pelvic examination or a battery of laboratory tests simply because they are starting birth control. For most method starts, that is not the standard requirement.

Guidance from the CDC’s Selected Practice Recommendations distinguishes between tests that are necessary for safe initiation and tests that may be useful for another reason. A blood pressure measurement is important before starting combined hormonal contraception. A pelvic examination is generally not needed before starting pills, the patch, the ring, an implant, or an injection. Pregnancy testing may be offered or recommended in some circumstances, but a test is not universally required when the clinician can be reasonably certain that the patient is not pregnant.

The table is a map, not a promise that every clinic will follow the same workflow. Local policies, access to equipment, a patient’s symptoms, and the possibility of pregnancy can change what is requested.

Blood pressure is especially relevant to estrogen

Combined hormonal methods contain estrogen and progestin. Estrogen-related cardiovascular risk is assessed alongside blood pressure, smoking, migraine history, age, clotting history, and other factors. A single elevated reading does not necessarily settle the issue, particularly if it was taken during pain, anxiety, or illness. But a clinician should know about a diagnosis of hypertension and any treatment you receive.

If you are seeking care through telehealth, ask in advance what kind of blood pressure reading the service accepts. A validated home cuff, a recent pharmacy reading, or a measurement from another healthcare visit may be useful, provided it is recent and reliable. Record the date, the reading, and whether you had been resting beforehand.

Pregnancy testing is conditional, not a universal insertion ritual

Clinics often perform a urine pregnancy test before an IUD or implant insertion, and they may perform one before starting other methods as well. That does not mean testing is universally required in every contraceptive visit. The key question is whether the clinician can be reasonably certain that you are not pregnant based on your menstrual history, recent sexual activity, current method use, and any other relevant facts.

If pregnancy cannot be reasonably excluded, a test may be appropriate, but a negative test very soon after intercourse may not answer every question. The clinician may recommend delaying insertion, repeating testing, using a temporary method, or discussing emergency contraception. These decisions depend on timing and on the method being considered.

An IUD must not be inserted during a known pregnancy. The reason for careful assessment is not that every patient must undergo the same test, but that insertion needs to be safe and clinically appropriate. Implant placement also requires a pregnancy assessment before insertion, while the exact process may vary according to the circumstances.

A pelvic exam is not a default contraceptive exam

Starting a pill, patch, ring, progestin-only pill, implant, or injection does not usually require a pelvic examination. Cervical cancer screening follows its own schedule and should not be bundled into contraception care unless it is due or there is another reason to perform it.

An IUD insertion is different because the procedure requires the clinician to examine the cervix and uterus. A pelvic examination may also be indicated for symptoms such as unexplained bleeding, pelvic pain, abnormal discharge, or concern about infection. If an exam is suggested solely because you are requesting birth control, it is reasonable to ask what clinical question the exam is intended to answer. That question is not confrontational; it helps separate routine contraception from care that addresses a symptom or screening need.

Strategic questions for shared decision-making

Shared decision-making is not a courtesy added after the medical screening. It is the part of the consultation where your priorities are given the same practical weight as the method’s eligibility and effectiveness.

A clinician may know which options are medically available. You know whether a daily task is realistic, whether irregular bleeding would be tolerable, whether privacy is a concern, how quickly you want fertility to return, and whether you can reliably return for an appointment. The recommendation is better when both kinds of knowledge are on the table.

These are useful questions to adapt to your situation:

1. Given my health history, which methods should we rule out before we compare preferences?

This puts safety first without allowing the entire conversation to become a list of restrictions.

2. What is the typical-use effectiveness of each option, and what usually explains failures?

Perfect-use figures describe an ideal. Typical-use effectiveness also reflects missed pills, delayed injections, incorrect condom use, late replacement of a ring or patch, and interruptions in access.

3. What bleeding pattern is common at the beginning, and what changes should prompt a call?

Spotting and irregular bleeding can occur after starting several methods, especially during the first months. You should also know which patterns are not something to simply wait out.

4. Which side effects are expected to settle, and which would make you recommend a switch or an examination?

Headache, mood changes, breast tenderness, nausea, and bleeding changes need context. A new severe headache, symptoms suggestive of a clot, very high blood pressure, or another urgent symptom should not be treated as ordinary adjustment.

5. How quickly can I stop or reverse this method, and what is known about return to fertility?

Fertility generally returns quickly after removal of an IUD or implant and after stopping pills, the patch, or the ring. Injectable contraception can have a longer delay before ovulation resumes for some people. If pregnancy is a possibility in the near future, this distinction belongs in the initial discussion.

6. What will this method require from me after today?

Ask about refills, replacement dates, injections, string checks if recommended by the clinic, self-administration training, and what to do after a missed dose or late appointment.

7. What will it cost, and what happens if I lose coverage or move?

A method that is affordable and accessible is more useful than one that works only while every appointment and pharmacy pickup goes smoothly. Discuss generic alternatives, supply limits, insertion or removal fees, and where follow-up would take place.

8. Does this method protect against sexually transmitted infections?

Contraception and STI prevention are related but not interchangeable. Condoms and internal condoms can reduce STI transmission risk when used correctly; most hormonal methods, IUDs, implants, and injections do not provide that protection.

The questions do not need to be delivered as a performance. Choose the two or three issues most likely to determine whether you can continue the method: bleeding, hormones, privacy, daily effort, pain, cost, reversibility, or protection from pregnancy at a particular time.

Telehealth versus in-person visits

Telehealth can handle much of contraceptive care, but it is not simply an in-person appointment moved onto a screen. Its usefulness depends on the method, the information available, and whether the person has symptoms that need an examination.

A remote visit may be suitable for:

• starting or renewing combined oral contraceptives when the necessary blood pressure information is available;
• discussing or prescribing progestin-only pills;
• renewing or changing a patch or ring;
• reviewing side effects and deciding whether to continue or switch;
• counseling about fertility-awareness methods;
• discussing emergency contraception;
• arranging an IUD or implant appointment;
• discussing injectable contraception and whether self-administration is appropriate.

The injectable category needs particular care. Some Depo-Provera formulations are administered by a healthcare professional, while the subcutaneous formulation may be self-administered by a patient who has received appropriate instruction and is considered suitable for that approach. Therefore, a blanket rule that the first dose must always be given in person is inaccurate. Ask which formulation is being prescribed, who is expected to administer it, how training will be provided, and what to do if an injection is late.

In-person care remains necessary for procedures such as IUD insertion or removal and implant insertion or removal. It is also important when a clinician needs to evaluate pelvic pain, suspected infection, unexplained bleeding, a concerning blood pressure reading, or another symptom that cannot be assessed adequately through a remote conversation.

For a telehealth appointment, prepare the same information you would bring to a clinic:

• the date of your last period and any uncertainty about it;
• a current medication and supplement list;
• relevant diagnoses and previous contraceptive experiences;
• a recent blood pressure reading if combined hormonal contraception is being considered;
• the dates of missed pills, late injections, or unprotected sex if they affect the decision;
• two or three questions you want answered before the visit ends.

If you cannot measure your blood pressure at home, say so rather than guessing. The clinic may arrange an in-person reading or offer a method for which that measurement is not required. Telehealth should reduce unnecessary barriers, not turn missing information into a reason for unsafe prescribing.

Addressing past experiences and method dissatisfaction

If you have already tried one or more methods, the next consultation should name the first experience clearly. A clinician can work with: combined pills used for two years, stopped because bleeding became persistent and headaches worsened. It is much harder to work with: birth control did not work for me.

Side-effect tracking is useful when it captures a timeline rather than merely collecting symptoms. Bring an app record, a paper diary, or screenshots if you have them. Note:

• the method, dose, or formulation;
• when each symptom began;
• whether it was present before the method;
• the pattern of bleeding and the timing of active and placebo pills, if applicable;
• missed doses, late changes, illness, or other disruptions;
• what improved or worsened the symptom;
• whether the symptom continued after stopping.

This level of detail does not prove that contraception caused a symptom. It gives the clinician enough context to decide whether the symptom is likely to be an expected effect, a sign that the method is a poor fit, or a separate issue requiring evaluation.

Dissatisfaction also has logistical causes. A daily pill may be medically suitable but impractical for someone with irregular shifts, unstable housing, privacy concerns, or difficulty obtaining monthly refills. An implant may remove the daily burden but raise concerns about bleeding or insertion. An IUD may fit someone’s priorities but require a conversation about the procedure, pain management, access, and follow-up. A method is not successful merely because it is effective when used under ideal conditions. It has to remain usable in the life of the person choosing it.

A previous method that was stopped because of a partner change still belongs in the history. So does a method stopped because contraception was no longer needed, because access became difficult, or because the person wanted a break from hormones. Years later, health conditions, medications, smoking status, blood pressure, reproductive plans, and tolerance for particular side effects may all be different. Returning to contraception is not necessarily starting from zero, but it is also not a command to repeat the old choice.

When a previous method was associated with an unintended pregnancy, avoid reducing the event to a question of personal discipline. Ask what happened around the method: missed doses, vomiting or severe diarrhea, an interaction with another medicine, delayed replacement, difficulty obtaining supplies, or uncertainty about instructions. The answer may point toward a different formulation, a backup plan, a long-acting method, or better access support.

The honest bottom line

There is no contraceptive method that is best for everyone, and there is no single consultation format that works for every situation. The point of preparation is not to arrive with a decision already made. It is to make the decision specific enough to be shared: medically safe, realistically maintainable, and acceptable to you.

Guidance that limits unnecessary barriers matters. Routine pelvic exams and broad laboratory testing are not prerequisites for most contraceptive starts. At the same time, removing unnecessary requirements does not remove the need for an accurate medical history, a pregnancy assessment when clinically needed, blood pressure information for combined hormonal methods, or an in-person visit for procedures.

A prepared visit may end with a prescription, a method that can be started immediately, a pregnancy test or blood pressure check before proceeding, a referral for insertion, or a decision to consider another option. None of these outcomes requires you to become your own clinician. They require you to be concrete.

Bring the menstrual timeline, the medication list, the conditions you know about, and the details of what happened with previous methods. Be ready to discuss smoking and other cardiovascular risks without relying on shorthand rules. Ask how the method affects bleeding, what side effects deserve attention, how it will fit into your routine, and what happens if your circumstances change.

The clinician brings the eligibility framework. You bring the context. A contraceptive consultation works best when neither side is expected to guess.